AmerisourceBergen
AmerisourceBergen (now Cencora) is a global pharmaceutical solutions organisation providing pharmaceutical and specialty distribution, manufacturer and provider services, and animal health solutions.
AmerisourceBergen, which rebranded to Cencora in August 2023, is a global pharmaceutical solutions organisation active in pharmaceutical distribution, specialty distribution, and manufacturer and provider services. The company employs more than 44,000 people across over 1,300 locations worldwide, reports annual revenue in excess of $200 billion, and ranks 11th on the Fortune 500. Its operations extend to animal health, serving veterinary and animal health providers alongside its human healthcare business.
The company's core business is wholesale pharmaceutical distribution, moving medications to their destinations with an emphasis on reliability, efficiency, and security. Its specialty distribution arm serves specialty pharmacies, haemophilia centres, and home healthcare companies, and the organisation states that it serves 100 per cent of US hospitals. Beyond distribution, AmerisourceBergen provides manufacturer support services that partner with pharmaceutical innovators across the value chain to optimise market access to therapies, as well as provider services supporting care delivery.
Technical domains within the organisation span supply chain and logistics, market access optimisation, specialty distribution, and animal health solutions. Its stated purpose is improving access to healthcare for people and animals worldwide and advancing the development and delivery of pharmaceuticals. The rebrand to Cencora was intended to reflect a growing global role in pharmaceutical access and care.